- Details
- Ashish Kamat, MD, MBBS welcomes Neema Navai, MD, to this Bladder Cancer Center of Excellence discussion. Dr. Navai researches minimally metastatic and metastatic bladder cancer where surgical therapy can be implemented. Starting with a case study of a patient diagnosed with bladder cancer with an involved pelvic lymph node, Dr. Navai describes how outcomes regarding the use of surgery and chemothe...
|
- Details
- Makarand Khochikar, MS DNB, Dip Urol, FRCS, FEBU, presents a case study evaluating the care of a pregnant woman with bladder cancer, in a discussion with Ashish Kamat, MD, MBBS. Dr. Kamat discusses balancing the health of the mother and the health of the fetus, and Dr. Khochikar reviews the treatment the patient was given, including muscle-sparing resection of the tumor. Dr. Khochikar and Dr. Kama...
|
- Details
- Justin Matulay, MD, joins Ashish Kamat, MD, MBBS, to review his work assessing the variability in guideline management and adherence for non-muscle Invasive Bladder Cancer (NMIBC) among members of the Society for Urologic Oncology (SUO). As bladder cancer poses a significant risk to the population and most diagnoses are non-muscle invasive, Dr. Matulay and colleagues at MD Anderson Cancer Center w...
|
- Details
- Ashish Kamat, MD, MBBS welcomes Renu Eapen, MD, to the UroToday Bladder Cancer Center of Excellence to dissect the gender-related differences in oncological and functional outcomes post-radical cystectomy. Women have been shown to face worse oncological outcomes with bladder cancer; explanations for this include social determinants such as initial diagnosis of urinary tract infection (UTI) prior t...
|
- Details
- Rafael Sanchez Salas, MD, from the Montsouris Institute in France joins Ashish Kamat, MD, MBBS, to provide his perspective on essential components of a radical cystectomy. Radical cystectomy is the standard of care for patients with muscle-invasive bladder cancer and those with high-grade non-muscle invasive bladder cancer, and it comes with the risk of complications and adverse outcomes. Dr. Sala...
|
- Details
- Makarand Khochikar, MS DNB, Dip Urol, FRCS, FEBU, presents a case of a patient with muscle-invasive bladder cancer undergoing surgery to remove the bladder and urinary diversion with a neobladder. Dr. Khochikar discusses the results of the patient's cystectomy and describes how the patient showed malrotation of the gut, which required Dr. Khochikar to contemplate options during surgery as to how t...
|
- Details
- Ashish Kamat is joined by Colin Dinney to discuss the results of the SUO-CTC Phase 3 Trial of nadofaragene firadenovec for patients with non-muscle invasive bladder cancer unresponsive to BCG. Dr. Dinney presents slides and discusses how most NMIBC patients recur despite BCG therapy, and there is an unmet need for therapies in patients' refractory to BCG. Previously, Nadofaragene firadenovec was t...
|
- Details
- Anne Schuckman, MD, MBBS, presents a summary of her plenary session presentation from the AUA 2020 live virtual conference on benefits of Blue Light Cystoscopy (BLC ® ) with Cysview ® , in a conversation with Ashish Kamat, MD. Dr. Schuckman details how Cysview can be used to visualize bladder tumors and highlights benefits arising from this technique including an increased ability to resect the tu...
|
- Details
- Ashish Kamat is joined by Veeru Kasivisvanathan, Kevin Gallagher, and Nikita Bhatt — members of the global research group British Urology Researchers in Surgical Training (BURST) — discussing the global RESECT study. Transurethral REsection and Single instillation intravesical chemotherapy Evaluation in bladder Cancer Treatment (RESECT) Improving quality in TURBT surgery. The RESECT study investig...
|
- Details
- Ashish Kamat, MD, MBBS is joined by Sima Porten, MD, MPH and Joshua Meeks, MD, PhD, panelist in the American Urological Association (AUA) Guidelines Case-Based Panel Discussion on Non-muscle and Muscle Invasive Bladder Cancer AUA 2020 plenary presentation. They provide their perspectives on bladder cancer patient guidelines-based management and the specific management of bladder cancer patients. B...
|
